UK Neuroscience RPA
@neurosciencerpa.bsky.social
The guiding strategy of the University of Kentucky Neuroscience Research Priority Area (NRPA) is to provide broad-based support to neuroscience researchers across the university.
We end our 2025 Neuroscience Symposium with Madison Kilgore presenting her research, “Sildenafil Improves Mitochondrial, Vascular, and Behavioral Outcomes Following Repeated Mild Blast Traumatic Brain Injury.”
November 7, 2025 at 8:38 PM
We end our 2025 Neuroscience Symposium with Madison Kilgore presenting her research, “Sildenafil Improves Mitochondrial, Vascular, and Behavioral Outcomes Following Repeated Mild Blast Traumatic Brain Injury.”
Vivek Pandey, PhD, is our fourth speaker with his talk, “Noninvasive Spinal Neuromodulation to Stabilize the Blood Pressure Pendulum After Spinal Cord Injury.”
November 7, 2025 at 8:23 PM
Vivek Pandey, PhD, is our fourth speaker with his talk, “Noninvasive Spinal Neuromodulation to Stabilize the Blood Pressure Pendulum After Spinal Cord Injury.”
Elika Moallem, MS, is our third speaker in our final session with “Sex-Dependent Effects of Ketone Therapy After TBI Reveal a Dichotomy in Mitochondrial Response and Metabolism in an Alzheimer's Disease Model.”
November 7, 2025 at 8:10 PM
Elika Moallem, MS, is our third speaker in our final session with “Sex-Dependent Effects of Ketone Therapy After TBI Reveal a Dichotomy in Mitochondrial Response and Metabolism in an Alzheimer's Disease Model.”
Our second speaker in our Neurotherapeutics session is Sajeev Kaur, PhD: Effect of Clodronate on Cardiovascular Dysfunction After Acute Severe High-Thoracic Spinal Cord Injury in Adult Female Rats.
November 7, 2025 at 7:51 PM
Our second speaker in our Neurotherapeutics session is Sajeev Kaur, PhD: Effect of Clodronate on Cardiovascular Dysfunction After Acute Severe High-Thoracic Spinal Cord Injury in Adult Female Rats.
Our final session, Neurotherapeutics, covers traumatic brain injuries and spinal cord injuries. Velmurugan Gopal Viswanathan, PhD, starts this session with his talk, “Astrocytic Mitochondrial Transfer and Transplantation as Therapeutic Strategies for Traumatic Brain Injury.”
November 7, 2025 at 7:34 PM
Our final session, Neurotherapeutics, covers traumatic brain injuries and spinal cord injuries. Velmurugan Gopal Viswanathan, PhD, starts this session with his talk, “Astrocytic Mitochondrial Transfer and Transplantation as Therapeutic Strategies for Traumatic Brain Injury.”
Our Stroke Session concludes with Justin Huber, MD: Computer Vision to Extract Post-Stroke Biomechanics of Upper Limb Recovery: Preliminary Results of an Ongoing Clinical Study.
November 7, 2025 at 7:06 PM
Our Stroke Session concludes with Justin Huber, MD: Computer Vision to Extract Post-Stroke Biomechanics of Upper Limb Recovery: Preliminary Results of an Ongoing Clinical Study.
The fourth talk in our Stroke Session is from Keith Pennypacker, PhD: Sex Differences in Proteomic Response to Ischemic Stroke.
November 7, 2025 at 6:51 PM
The fourth talk in our Stroke Session is from Keith Pennypacker, PhD: Sex Differences in Proteomic Response to Ischemic Stroke.
Christopher McLouth, PhD talks about “Linking EMS and In-Hospital Stroke Records: Impact of Deterministic vs. Probabilistic Methods on Selection Bias” for the third presentation in our Stroke Session.
November 7, 2025 at 6:34 PM
Christopher McLouth, PhD talks about “Linking EMS and In-Hospital Stroke Records: Impact of Deterministic vs. Probabilistic Methods on Selection Bias” for the third presentation in our Stroke Session.
The second presentation is Baseline Sex Differences and Minimal Stroke-Induced Immune
Activity of the Choroid Plexus in Aged Mice, by Annabel McAtee.
Activity of the Choroid Plexus in Aged Mice, by Annabel McAtee.
November 7, 2025 at 6:29 PM
The second presentation is Baseline Sex Differences and Minimal Stroke-Induced Immune
Activity of the Choroid Plexus in Aged Mice, by Annabel McAtee.
Activity of the Choroid Plexus in Aged Mice, by Annabel McAtee.
Our second session covers Stroke/Neurovascular conditions. The first presenter is Madison Bates, PhD: Characterizing Hand Function in Stroke and Healthy Adults During Activities of Daily Living Using the SensorE Exoskeleton: A Feasibility Study.
November 7, 2025 at 6:05 PM
Our second session covers Stroke/Neurovascular conditions. The first presenter is Madison Bates, PhD: Characterizing Hand Function in Stroke and Healthy Adults During Activities of Daily Living Using the SensorE Exoskeleton: A Feasibility Study.
The last two talks finish our first session strong!
Sophiya Sims: Characterizing Bioenergetic Status of Neurons and Astrocytes Using
2P Imaging Techniques
Karen Sofia Zuluaga-Osorio, MS: Astrocytic NFAT Signaling as a Driver of Tau Pathology in a Mouse Model of Tauopathy
Sophiya Sims: Characterizing Bioenergetic Status of Neurons and Astrocytes Using
2P Imaging Techniques
Karen Sofia Zuluaga-Osorio, MS: Astrocytic NFAT Signaling as a Driver of Tau Pathology in a Mouse Model of Tauopathy
November 7, 2025 at 4:20 PM
The last two talks finish our first session strong!
Sophiya Sims: Characterizing Bioenergetic Status of Neurons and Astrocytes Using
2P Imaging Techniques
Karen Sofia Zuluaga-Osorio, MS: Astrocytic NFAT Signaling as a Driver of Tau Pathology in a Mouse Model of Tauopathy
Sophiya Sims: Characterizing Bioenergetic Status of Neurons and Astrocytes Using
2P Imaging Techniques
Karen Sofia Zuluaga-Osorio, MS: Astrocytic NFAT Signaling as a Driver of Tau Pathology in a Mouse Model of Tauopathy
The 3rd presentation in the Neurodegenerative Disorders session is from Khine Zin Aung, MD, PhD: Gaps in the Genetic Landscape of Neurodegenerative
Disorders: Multi-Allelic Variants
Disorders: Multi-Allelic Variants
November 7, 2025 at 3:49 PM
The 3rd presentation in the Neurodegenerative Disorders session is from Khine Zin Aung, MD, PhD: Gaps in the Genetic Landscape of Neurodegenerative
Disorders: Multi-Allelic Variants
Disorders: Multi-Allelic Variants
The Neurodegenerative Disorders session is off to a great start!
Hiba Khan, MS: Early Detection of Parkinson's Disease in RBD Patients Using Alpha-Synuclein as a Biomarker
Samuel Lundt, PhD: Investigating PAD4 Activity on TDP-43 Pathology in
FTD Mice
Hiba Khan, MS: Early Detection of Parkinson's Disease in RBD Patients Using Alpha-Synuclein as a Biomarker
Samuel Lundt, PhD: Investigating PAD4 Activity on TDP-43 Pathology in
FTD Mice
November 7, 2025 at 3:38 PM
The Neurodegenerative Disorders session is off to a great start!
Hiba Khan, MS: Early Detection of Parkinson's Disease in RBD Patients Using Alpha-Synuclein as a Biomarker
Samuel Lundt, PhD: Investigating PAD4 Activity on TDP-43 Pathology in
FTD Mice
Hiba Khan, MS: Early Detection of Parkinson's Disease in RBD Patients Using Alpha-Synuclein as a Biomarker
Samuel Lundt, PhD: Investigating PAD4 Activity on TDP-43 Pathology in
FTD Mice
Full house for Dr. Walsh’s keynote presentation!
November 7, 2025 at 2:14 PM
Full house for Dr. Walsh’s keynote presentation!
The 10th Annual Neuroscience Clinical-Translational Research Symposium is off to a great start with the general poster session! Come check out the 72 amazing posters being presented until 2:30pm today. 👀
November 6, 2025 at 6:07 PM
The 10th Annual Neuroscience Clinical-Translational Research Symposium is off to a great start with the general poster session! Come check out the 72 amazing posters being presented until 2:30pm today. 👀
Reposted by UK Neuroscience RPA
At the @uksbcoa.bsky.social, David Fardo’s research is driving breakthroughs in understanding dementia. His goal is to find answers for Kentucky families.
Learn how NIH funding is crucial to that mission: research.uky.edu/news/researc...
Learn how NIH funding is crucial to that mission: research.uky.edu/news/researc...
May 12, 2025 at 6:54 PM
At the @uksbcoa.bsky.social, David Fardo’s research is driving breakthroughs in understanding dementia. His goal is to find answers for Kentucky families.
Learn how NIH funding is crucial to that mission: research.uky.edu/news/researc...
Learn how NIH funding is crucial to that mission: research.uky.edu/news/researc...
Reposted by UK Neuroscience RPA
UK’s research “trifecta” of NIH-funded centers — Sanders-Brown Center on Aging, CCTS and Markey Cancer Center — drive breakthroughs in aging, translational science and cancer research.
Learn more: research.uky.edu/news/how-nih...
Learn more: research.uky.edu/news/how-nih...
May 6, 2025 at 11:14 AM
UK’s research “trifecta” of NIH-funded centers — Sanders-Brown Center on Aging, CCTS and Markey Cancer Center — drive breakthroughs in aging, translational science and cancer research.
Learn more: research.uky.edu/news/how-nih...
Learn more: research.uky.edu/news/how-nih...
Reposted by UK Neuroscience RPA
Research that transforms brain health is the goal of @uksbcoa.bsky.social.
Dr. Linda Van Eldik explains how NIH funding is crucial to advancing this important work.
Learn more: research.uky.edu/news/researc...
Dr. Linda Van Eldik explains how NIH funding is crucial to advancing this important work.
Learn more: research.uky.edu/news/researc...
May 6, 2025 at 3:01 PM
Research that transforms brain health is the goal of @uksbcoa.bsky.social.
Dr. Linda Van Eldik explains how NIH funding is crucial to advancing this important work.
Learn more: research.uky.edu/news/researc...
Dr. Linda Van Eldik explains how NIH funding is crucial to advancing this important work.
Learn more: research.uky.edu/news/researc...
Reposted by UK Neuroscience RPA
Keeping golden years golden — Dr. Greg Jicha at UK's Sanders-Brown Center on Aging is leading research to combat Alzheimer’s and dementia in Kentucky. Discover how NIH funding makes that possible.
Learn more: www.research.uky.edu/news/researc...
Learn more: www.research.uky.edu/news/researc...
April 30, 2025 at 7:51 PM
Keeping golden years golden — Dr. Greg Jicha at UK's Sanders-Brown Center on Aging is leading research to combat Alzheimer’s and dementia in Kentucky. Discover how NIH funding makes that possible.
Learn more: www.research.uky.edu/news/researc...
Learn more: www.research.uky.edu/news/researc...
Reposted by UK Neuroscience RPA
Research drives discovery at UK.
Funding from the NIH makes a difference. UK Acting Vice President for Research Ilhem Messaoudi explains how this funding impacts Kentuckians.
Learn more: www.research.uky.edu/news/researc...
Funding from the NIH makes a difference. UK Acting Vice President for Research Ilhem Messaoudi explains how this funding impacts Kentuckians.
Learn more: www.research.uky.edu/news/researc...
April 28, 2025 at 3:24 PM
Research drives discovery at UK.
Funding from the NIH makes a difference. UK Acting Vice President for Research Ilhem Messaoudi explains how this funding impacts Kentuckians.
Learn more: www.research.uky.edu/news/researc...
Funding from the NIH makes a difference. UK Acting Vice President for Research Ilhem Messaoudi explains how this funding impacts Kentuckians.
Learn more: www.research.uky.edu/news/researc...
Reposted by UK Neuroscience RPA
Darlingtina K. Esiaka, a researcher with the UK College of Medicine, has been awarded a fellowship to travel to Nigeria and work with the Research Center for Ageing Cognition and Psychological Health at Nnamdi Azikiwe University.
Learn more: www.research.uky.edu/news/uk-rese...
Learn more: www.research.uky.edu/news/uk-rese...
April 4, 2025 at 5:10 PM
Darlingtina K. Esiaka, a researcher with the UK College of Medicine, has been awarded a fellowship to travel to Nigeria and work with the Research Center for Ageing Cognition and Psychological Health at Nnamdi Azikiwe University.
Learn more: www.research.uky.edu/news/uk-rese...
Learn more: www.research.uky.edu/news/uk-rese...
Reposted by UK Neuroscience RPA
The 𝟏𝟕𝐭𝐡 𝐀𝐧𝐧𝐮𝐚𝐥 𝐌𝐢𝐧𝐝 𝐌𝐚𝐭𝐭𝐞𝐫𝐬 𝐇𝐞𝐚𝐥𝐭𝐡 𝐅𝐚𝐢𝐫 is approaching! We hope you will join us! @neurosciencerpa.bsky.social @ukresearch.bsky.social
April 8, 2025 at 5:42 PM
The 𝟏𝟕𝐭𝐡 𝐀𝐧𝐧𝐮𝐚𝐥 𝐌𝐢𝐧𝐝 𝐌𝐚𝐭𝐭𝐞𝐫𝐬 𝐇𝐞𝐚𝐥𝐭𝐡 𝐅𝐚𝐢𝐫 is approaching! We hope you will join us! @neurosciencerpa.bsky.social @ukresearch.bsky.social
Reposted by UK Neuroscience RPA
We were thrilled to share the importance of new therapies for Alzheimer's! Thank you @istaart.bsky.social
📢Tune in to ISTAART Voices!
Drs. Gregory Jicha and Peter Nelson compare emerging anti-amyloid therapies to biologics used in cancer and other diseases. This conversation highlights novel therapies transforming Alzheimer's treatment!
Listen now at alz.org/ISTAARTpodca...! 🎧
Drs. Gregory Jicha and Peter Nelson compare emerging anti-amyloid therapies to biologics used in cancer and other diseases. This conversation highlights novel therapies transforming Alzheimer's treatment!
Listen now at alz.org/ISTAARTpodca...! 🎧
April 4, 2025 at 12:58 PM
We were thrilled to share the importance of new therapies for Alzheimer's! Thank you @istaart.bsky.social
Reposted by UK Neuroscience RPA
Kudos to 𝐕𝐚𝐧 𝐄𝐥𝐝𝐢𝐤 lab members 𝐂𝐚𝐥𝐞𝐛 𝐁𝐚𝐢𝐥𝐞𝐲 & 𝐌𝐜𝐊𝐞𝐧𝐧𝐚 𝐆𝐫𝐞𝐞𝐧 as they share their research at #ADPD2025!
#cytokines #p38a
#cytokines #p38a
April 2, 2025 at 4:49 PM
Kudos to 𝐕𝐚𝐧 𝐄𝐥𝐝𝐢𝐤 lab members 𝐂𝐚𝐥𝐞𝐛 𝐁𝐚𝐢𝐥𝐞𝐲 & 𝐌𝐜𝐊𝐞𝐧𝐧𝐚 𝐆𝐫𝐞𝐞𝐧 as they share their research at #ADPD2025!
#cytokines #p38a
#cytokines #p38a
Reposted by UK Neuroscience RPA
A great write up on our recent work in PNAS attempting to understand metabolic drivers of sleep, led by @ncons95.bsky.social !
uknow.uky.edu/research/fue...
uknow.uky.edu/research/fue...
Fueling sleep: UK researchers show key metabolic link to restful nights
Scientists have long recognized the brain’s need for energy, but groundbreaking research from the University of Kentucky’s Sanders-Brown Center on Aging has now illuminated how the brain’s energy uti...
uknow.uky.edu
March 27, 2025 at 2:02 PM
A great write up on our recent work in PNAS attempting to understand metabolic drivers of sleep, led by @ncons95.bsky.social !
uknow.uky.edu/research/fue...
uknow.uky.edu/research/fue...